Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

459 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive Factors for Successful Vaccination Against Hepatitis B Surface Antigen in Patients Who Have Undergone Orthotopic Liver Transplantation.
Ikeda A, Takaki A, Yasunaka T, Oyama A, Adachi T, Wada N, Onishi H, Ikeda F, Shiraha H, Yoshida K, Kuise T, Nobuoka D, Yoshida R, Umeda Y, Yagi T, Fujiwara T, Okada H. Ikeda A, et al. Among authors: ikeda f. Acta Med Okayama. 2019 Feb;73(1):41-50. doi: 10.18926/AMO/56457. Acta Med Okayama. 2019. PMID: 30820053 Free article.
Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?
Takaki A, Yagi T, Yasunaka T, Sadamori H, Shinoura S, Umeda Y, Yoshida R, Sato D, Nobuoka D, Utsumi M, Yasuda Y, Nakayama E, Miyake Y, Ikeda F, Shiraha H, Nouso K, Fujiwara T, Yamamoto K. Takaki A, et al. Among authors: ikeda f. J Gastroenterol. 2013 Dec;48(12):1373-83. doi: 10.1007/s00535-013-0763-8. Epub 2013 Feb 23. J Gastroenterol. 2013. PMID: 23435670 Free PMC article.
Prevalence and outcomes of acute hepatitis B in Okayama, Japan, 2006-2010.
Wada N, Yasunaka T, Ikeda F, Nishina S, Korenaga M, Hino K, Fujioka S, Osawa T, Itoshima T, Kawanaka M, Yamada G, Kariyama K, Takayama H, Kubota J, Morimoto Y, Mizushima T, Yamashita H, Tanioka H, Negoro Y, Toshimori J, Kobashi H, Hirano A, Itano Y, Takaki A, Yamamoto K. Wada N, et al. Among authors: ikeda f. Acta Med Okayama. 2014;68(4):243-7. doi: 10.18926/AMO/52790. Acta Med Okayama. 2014. PMID: 25145410 Free article.
Hepatitis C virus-specific T-cell response correlates with hepatitis activity and donor IL28B genotype early after liver transplantation.
Tsuzaki R, Takaki A, Yagi T, Ikeda F, Koike K, Iwasaki Y, Shiraha H, Miyake Y, Sadamori H, Shinoura S, Umeda Y, Yoshida R, Nobuoka D, Utsumi M, Nakayama E, Fujiwara T, Yamamoto K. Tsuzaki R, et al. Among authors: ikeda f. Acta Med Okayama. 2014;68(5):291-302. doi: 10.18926/AMO/52898. Acta Med Okayama. 2014. PMID: 25338486 Free article.
Enhancement of Programmed Death Ligand 2 on Hepatitis C Virus Infected Hepatocytes by Calcineurin Inhibitors.
Koike K, Takaki A, Yagi T, Iwasaki Y, Yasunaka T, Sadamori H, Shinoura S, Umeda Y, Yoshida R, Sato D, Nobuoka D, Utsumi M, Miyake Y, Ikeda F, Shiraha H, Fujiwara T, Yamamoto K. Koike K, et al. Among authors: ikeda f. Transplantation. 2015 Jul;99(7):1447-54. doi: 10.1097/TP.0000000000000572. Transplantation. 2015. PMID: 25675203 Free PMC article.
A case of fulminant liver failure associated with hepatitis C virus.
Kanzaki H, Takaki A, Yagi T, Ikeda F, Yasunaka T, Koike K, Miyake Y, Iwasaki Y, Nouso K, Sadamori H, Shinoura S, Umeda Y, Yoshida R, Utusmi M, Fujiwara T, Yamamoto K. Kanzaki H, et al. Among authors: ikeda f. Clin J Gastroenterol. 2014 Apr;7(2):170-4. doi: 10.1007/s12328-014-0454-x. Epub 2014 Jan 18. Clin J Gastroenterol. 2014. PMID: 26183636
Entecavir Reduces Hepatocarcinogenesis in Chronic Hepatitis B Patients.
Yasunaka T, Ikeda F, Wada N, Morimoto Y, Fujioka S, Toshimori J, Kobashi H, Kariyama K, Morimoto Y, Takayama H, Seno T, Takaguchi K, Moriya A, Miyatake H, Okamoto R, Yabushita K, Takaki A, Yamamoto K. Yasunaka T, et al. Among authors: ikeda f. Acta Med Okayama. 2016;70(1):1-12. doi: 10.18926/AMO/53996. Acta Med Okayama. 2016. PMID: 26899604 Free article.
Mixed HCV Infection of Genotype 1B and Other Genotypes Influences Non-response during Daclatasvir + Asunaprevir Combination Therapy.
Wada N, Ikeda F, Mori C, Takaguchi K, Fujioka SI, Kobashi H, Morimoto Y, Kariyama K, Sakaguchi K, Hashimoto N, Moriya A, Kawaguchi M, Miyatake H, Hagihara H, Kubota J, Takayama H, Takeuchi Y, Yasunaka T, Takaki A, Iwasaki Y, Okada H. Wada N, et al. Among authors: ikeda f. Acta Med Okayama. 2018 Aug;72(4):401-406. doi: 10.18926/AMO/56178. Acta Med Okayama. 2018. PMID: 30140089 Free article.
459 results